FDA Drug Application (206352) for REYATAZ by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number206352
Product Number001
FormPOWDER;ORAL
DosageEQ 50MG BASE/PACKET
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameREYATAZ
Active IngredientATAZANAVIR SULFATE

Active IngredientCount
List of drugs with Active Ingredient ATAZANAVIR SULFATE6


Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB